Cell Biotech Co. Ltd Financial Flexibility Index
Cell Biotech Co. Ltd financial flexibility index. Cell Biotech Co. Ltd (049960) has a Financial Flexibility Index of 0.86x as of September 2025. Free cash flow of ₩6.44 Billion (operating CF ₩4.15 Billion minus capex ₩2.29 Billion) represents 1% of total liabilities (₩7.46 Billion). Explore Cell Biotech Co. Ltd (049960) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Cell Biotech Co. Ltd (2011–2024)
Financial flexibility index of Cell Biotech Co. Ltd from 2011 to 2024. Historical Financial Flexibility Index trend for Cell Biotech Co. Ltd across 14 annual periods. Check total reinvestment intensity of Cell Biotech Co. Ltd to assess the company's total reinvestment commitment from operating cash flow.
Cell Biotech Co. Ltd Financial Flexibility Index by Year (2011–2024)
Cell Biotech Co. Ltd financial flexibility index by year from 2011 to 2024. Year-by-year free cash flow to debt coverage for Cell Biotech Co. Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Cell Biotech Co. Ltd.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.30x | ₩20.55 Billion | ₩19.27 Billion | ₩6.23 Billion | ▲ +99.8% |
| 2023 | 1.65x | ₩9.50 Billion | ₩7.82 Billion | ₩5.76 Billion | ▼ -17.4% |
| 2022 | 2.00x | ₩15.49 Billion | ₩12.81 Billion | ₩7.75 Billion | ▼ -21.4% |
| 2021 | 2.54x | ₩15.74 Billion | ₩14.89 Billion | ₩6.19 Billion | ▲ +6.9% |
| 2020 | 2.38x | ₩12.64 Billion | ₩9.56 Billion | ₩5.32 Billion | ▼ -43.2% |
| 2019 | 4.19x | ₩19.70 Billion | ₩10.23 Billion | ₩4.70 Billion | ▲ +27.6% |
| 2018 | 3.28x | ₩21.09 Billion | ₩13.98 Billion | ₩6.42 Billion | ▼ -26.1% |
| 2017 | 4.44x | ₩27.88 Billion | ₩22.53 Billion | ₩6.28 Billion | ▲ +40.5% |
| 2016 | 3.16x | ₩20.15 Billion | ₩17.99 Billion | ₩6.38 Billion | ▼ -9.2% |
| 2015 | 3.48x | ₩21.62 Billion | ₩18.24 Billion | ₩6.21 Billion | ▲ +61.6% |
| 2014 | 2.15x | ₩11.29 Billion | ₩9.91 Billion | ₩5.24 Billion | ▼ -48.7% |
| 2013 | 4.20x | ₩15.30 Billion | ₩8.99 Billion | ₩3.65 Billion | ▲ +70.9% |
| 2012 | 2.45x | ₩9.53 Billion | ₩6.17 Billion | ₩3.88 Billion | ▲ +102.5% |
| 2011 | 1.21x | ₩6.04 Billion | ₩5.45 Billion | ₩4.98 Billion | — |